A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation
Abstract
:1. Introduction
2. Clinical Case
3. Discussion
4. Conclusions
Author Contributions
Funding
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Weatherall, D.J.; Clegg, J.B. Inherited haemoglobin disorders: An increasing global health problem. Bull. World Health Organ. 2001, 79, 704–712. [Google Scholar] [PubMed]
- Aygun, B.; Odame, I. A global perspective on sickle cell disease. Pediatr. Blood Cancer. 2012, 59, 386–390. [Google Scholar] [CrossRef] [PubMed]
- Modell, B.; Darlison, M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull. World Health Organ. 2008, 86, 480–487. [Google Scholar] [CrossRef] [PubMed]
- Liem, R.I.; Lanzkron, S.; Coates, T.D.; DeCastro, L.; Desai, A.A.; Ataga, K.I.; Cohen, R.T.; Haynes, J.; Osunkwo, I.; Lebensburger, J.D.; et al. American Society of Hematology 2019 guidelines for sickle disease: Cardiopulmonary and kidney disease. Blood Adv. 2019, 3, 3867–3897. [Google Scholar] [CrossRef]
- Guasch, A.; Navarrete, J.; Nass, K.; Zayas, C.F. Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure. J. Am. Soc. Nephrol. 2006, 17, 2228–2235. [Google Scholar] [CrossRef] [Green Version]
- Yee, M.M.; Jabbar, S.F.; Osunkwo, I.; Clement, L.; Lane, P.A.; Eckman, J.R.; Guasch, A. Chronic kidney disease and albuminuria in children with sickle cell disease. Clin. J. Am. Soc. Nephrol. 2011, 6, 2628–2633. [Google Scholar]
- McClellan, A.C.; Luthi, J.C.; Lynch, J.R.; Soucie, J.M.; Kulkarni, R.; Guasch, A.; Huff, E.D.; Gilbertson, D.; McClellan, W.M.; DeBaun, M.R. High one year mortality in adults with sickle cell disease and end-stage renal disease. Br. J. Haematol. 2012, 159, 360–367. [Google Scholar] [CrossRef]
- Montgomery, R.; Zibari, G.; Hill, G.S.; Ratner, L.E. Renal transplantation in patients with sickle cell nephropathy. Transplantation 1994, 58, 618–620. [Google Scholar] [CrossRef]
- Naik, R.P.; Streiff, M.B.; Haywood, C., Jr.; Segal, J.B.; Lanzkron, S. Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease. J. Thromb. Haemost. 2014, 12, 2010–2016. [Google Scholar] [CrossRef] [Green Version]
- Noubiap, J.J.; Temgoua, M.N.; Tankeu, R.; Tochie, J.N.; Wonkam, A.; Bigna, J.J. Sickle cell disease, sickle trait and the risk for venous thromboembolism: A systematic review and meta-analysis. Thromb. J. 2018, 16, 27. [Google Scholar] [CrossRef]
- Konstantinides, S.V.; Meyer, G.; Becattini, C.; Bueno, H.; Geersing, G.J.; Harjola, V.P.; Huisman, M.V.; Humbert, M.; Jennings, C.S.; Jiménez, D.; et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur. Heart. J. 2020, 41, 543–603. [Google Scholar] [CrossRef] [Green Version]
- Witt, D.M.; Nieuwlaat, R.; Clark, N.P.; Ansell, J.; Holbrook, A.; Skov, J.; Shehab, N.; Mock, J.; Myers, T.; Dentali, F.; et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: Optimal management of anticoagulation therapy. Blood Adv. 2018, 2, 3226–3256. [Google Scholar] [CrossRef]
- Kumar, R.; Stanek, J.; Creary, S.; Dunn, A.; O’Brien, S.H. Prevalence and risk factors for venous thromboembolism in children with sickle cell disease: An administrative database study. Blood Adv. 2018, 2, 285–291. [Google Scholar] [CrossRef] [Green Version]
- Brunson, A.; Lei, A.; Rosenberg, A.S.; White, R.H.; Keegan, T.; Wun, T. Increased incidence of VTE in sickle cell disease patients: Risk factors, recurrence and impact on mortality. Br. J. Haematol. 2017, 178, 319–326. [Google Scholar] [CrossRef] [Green Version]
- Makris, M.; Preston, F.E.; Beauchamp, N.J.; Cooper, P.C.; Daly, M.E.; Hampton, K.K.; Bayliss, P.; Peake, I.R.; Miller, G.J. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb. Haemost. 1997, 78, 1426–1429. [Google Scholar] [CrossRef]
- Ridker, P.M.; Hennekens, C.H.; Lindpaintner, K.; Stampfer, M.J.; Eisenberg, P.R.; Miletich, J.P. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N. Engl. J. Med. 1995, 332, 912–917. [Google Scholar] [CrossRef]
- De Moerloose, P.; Wutschert, R.; Heinzmann, M.; Perneger, T.; Reber, G.; Bounameaux, H. Superficial vein thrombosis of lower limbs: Influence of factor V Leiden, factor II G20210A and overweight. Thromb. Haemost. 1998, 80, 239–241. [Google Scholar]
- Ocak, G.; Vossen, C.Y.; Verduijn, M.; Dekker, F.W.; Rosendaal, F.R.; Cannegieter, S.C.; Lijfering, W.M. Risk of venous thrombosis in patients with major illnesses: Results from the MEGA study. J. Thromb. Haemost. 2013, 11, 116–123. [Google Scholar] [CrossRef]
- Huerta, C.; Johansson, S.; Wallander, M.A.; García Rodríguez, L.A. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch. Intern. Med. 2007, 167, 935–943. [Google Scholar] [CrossRef] [Green Version]
- Johannesdottir, S.A.; Horváth-Puhó, E.; Dekkers, O.M.; Cannegieter, S.C.; Jørgensen, J.O.; Ehrenstein, V.; Vandenbroucke, J.P.; Pedersen, L.; Sørensen, H.T. Use of glucocorticoids and risk of venous thromboembolism: A nationwide population-based case-control study. JAMA Intern. Med. 2013, 173, 743–752. [Google Scholar] [CrossRef] [Green Version]
- Poli, D.; Zanazzi, M.; Antonucci, E.; Marcucci, R.; Rosati, A.; Bertoni, E.; Salvadori, M.; Liotta, A.A.; Abbate, R.; Prisco, D.; et al. High rate of recurrence in renal transplant recipients after a first episode of venous thromboembolism. Transplantation 2005, 80, 789–793. [Google Scholar] [CrossRef]
- Andrassy, J.; Zeier, M.; Andrassy, K. Do we need screening for thrombophilia prior to kidney transplantation? Nephrol. Dial. Transplant. 2004, 4, 64–68. [Google Scholar] [CrossRef]
- Allen, R.D.; Michie, C.A.; Murie, J.A.; Morris, P.J. Deep venous thrombosis after renal transplantation. Surg. Gynecol. Obstet. 1987, 164, 137–142. [Google Scholar]
- Todeschini, P.; La Manna, G.; Dalmastri, V.; Feliciangeli, G.; Cuna, V.; Montanari, M.; Angelini, M.L.; Scolari, M.P.; Stefoni, S. Incidence of late deep venous thrombosis among renal transplant patients. Transplant Proc. 2013, 45, 2666–2668. [Google Scholar] [CrossRef]
- Poli, D.; Zanazzi, M.; Antonucci, E.; Bertoni, E.; Salvadori, M.; Abbate, R.; Prisco, D. Renal transplant recipients are at high risk for both symptomatic and asymptomatic deep vein thrombosis. J. Thromb. Haemost. 2006, 4, 988–992. [Google Scholar] [CrossRef]
- Galanaud, J.P.; Sevestre, M.A.; Pernod, G.; Kahn, S.R.; Genty, C.; Terrisse, H.; Brisot, D.; Gillet, J.L.; Quéré, I.; Bosson, J.L. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis. J. Thromb. Haemost. 2017, 15, 1123–1131. [Google Scholar] [CrossRef] [Green Version]
- Van Langevelde, K.; Lijfering, W.M.; Rosendaal, F.R.; Cannegieter, S.C. Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: Results from the MEGA study. Blood 2011, 118, 4239–4241. [Google Scholar] [CrossRef]
- Roach, R.E.J.; Lijfering, W.M.; van Hylckama Vlieg, A.; Helmerhorst, F.M.; Rosendaal, F.R.; Cannegieter, S.C. The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors. Blood 2013, 122, 4264–4269. [Google Scholar] [CrossRef]
Risk Factor of VTE | Type |
---|---|
Primary illness | Sickle cell disease |
Renal disease | Pathology pre-transplantation: nephrotic syndrome, peritoneal dialysis Renal transplantation |
Medication | Steroid therapy, tacrolimus, mycophenolate |
Previous VTE event | Two episodes of superficial venous thrombosis |
Congenital factor | Absence of mutations at the G20210A locus of Factor II and Factor V |
Splenectomy |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Di Maggio, R.; Giuliano, A.; Renda, D.; Calvaruso, G.; Raso, S.; Pitrolo, L.; Carroccio, A.; Maggio, A. A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation. Thalass. Rep. 2022, 12, 85-89. https://doi.org/10.3390/thalassrep12030013
Di Maggio R, Giuliano A, Renda D, Calvaruso G, Raso S, Pitrolo L, Carroccio A, Maggio A. A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation. Thalassemia Reports. 2022; 12(3):85-89. https://doi.org/10.3390/thalassrep12030013
Chicago/Turabian StyleDi Maggio, Rosario, Alessandra Giuliano, Disma Renda, Giuseppina Calvaruso, Simona Raso, Lorella Pitrolo, Antonio Carroccio, and Aurelio Maggio. 2022. "A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation" Thalassemia Reports 12, no. 3: 85-89. https://doi.org/10.3390/thalassrep12030013